Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies
SHANGHAI, April 6, 2021 /PRNewswire/ Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global biopharmaceutical company, to develop and commercialize multiple bi-specific antibodies (BsAb) based on monoclonal antibody developed by Genechem and antibodies selected by I-MAB. This collaboration is the first of many that will leverage Genechem s Good Research Practice (GRP) and CHAMP antibody discovery platform, strong bioinformatic database, as well as strong development expertise of synergistic partners, to deliver globally competitive assets based on innovative targets. We are excited to collaborate with I-Mab, a global leader in Oncology and antibody development, to bring more products to address clin
China
Shanghai
Kostenloser-wertpapierhandel
Yueqiong-cao
Good-research-practice
Research-oncologists
Genechem-good-research-practice
Shanghai-genchem-co-ltd
Prnewswire-shanghai-genechem-co-ltd
Nasdaq
Shanghai-genechem-co-ltd
சீனா